Stock Comparison
ABBV vs NVS
AbbVie Inc and Novartis AG ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$447.62B
$296.54B
P/E (TTM)
123.6
22.3
Forward P/E
17.8
17.6
Price/Sales
7.1
5.2
Price/Book
50.5
7.7
EV/EBITDA
30.2
15.1
Dividend Yield
2.77%
3.05%
Profitability
Net Margin
5.79%
23.90%
Operating Margin
32.20%
30.50%
Return on Equity
62.30%
34.90%
Return on Assets
10.00%
10.50%
Growth (YoY)
Revenue Growth
12.40%
-0.70%
Earnings Growth
-46.20%
-9.30%
Price & Risk
Beta
0.3
0.5
52-Week High
$253.35
$165.43
52-Week Low
$176.02
$109.02
Analyst Target
$254.38
$153.87
Compare ABBV and NVS your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.